23andMe CEO Anne Wojcicki explores taking DNA testing company private amid stock price decline.

23andMe CEO Anne Wojcicki is considering taking the DNA testing company private following a significant decline in its stock price. The company's shares have traded below $1 since late 2020, and Wojcicki is seeking to explore potential partners and financing sources for a possible acquisition. The CEO aims to maintain control of the company and has formed a Special Committee to evaluate strategic alternatives, including continuing to operate as a publicly traded company.